Jack West and Julia Rotow Discuss ADAURA Trial Takeaways

At ASCO 2023, the ADAURA trial made headlines in lung cancer. But does it raise more questions than it answers?
At ASCO 2023, the ADAURA trial made headlines in lung cancer. But does it raise more questions than it answers?

ASCO 2023

ASCO23 - LBA3: OS analysis from the ADAURA trial of adjuvant osimertinib in resected EGFR‐mutate

ESMO expert consensus statements on the management of EGFR mutant Non-Small Cell Lung Cancer

Mother and others

Ally mccoist Unbearable awareness is

eTrueSports - Worldwide Sports, eSports & Gaming Chronicles, and Tech Marvels Unveiled

A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of AMG 510 in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreak 100)

For NSCLC Neoadjuvant Adjuvant or Both

Jack West's Instagram, Twitter & Facebook on IDCrawl

Jack West's Instagram, Twitter & Facebook on IDCrawl

ASCO23 - LBA3: OS analysis from the ADAURA trial of adjuvant osimertinib in resected EGFR‐mutate

Jack West's Instagram, Twitter & Facebook on IDCrawl